author-photo

Ravindra Ganesh

Mayo Clinic

38

Papers

126

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

Reply to Puing et al.

2021 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients

2021
Show All
- Source
- Cite
- Save
Citations (0)
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19.

2021 Organic Process Research & Development
Show All
- Source
- Cite
- Save
Citations (1)
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19.

2021 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (3)
Clinical Prioritization of Anti-Spike Monoclonal Antibody Treatment of Mild to Moderate COVID-19

2021
Show All
- Source
- Cite
- Save
Citations (1)
Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome.

2021 Journal of Primary Care & Community Health
Show All
- Source
- Cite
- Save
Citations (1)
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (3)
Outcomes of Anti-Spike Monoclonal Antibody Therapy in Pregnant Women with Mild to Moderate COVID-19

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab among High-Risk Patients with Mild to Moderate Coronavirus Disease 2019.

2021 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (5)
A Framework for Outpatient Infusion of Anti-Spike Monoclonal Antibodies to High-Risk Patients with Mild to Moderate Coronavirus Disease-19: The Mayo Clinic Model

2021
Show All
- Source
- Cite
- Save
Citations (12)